comparemela.com

Latest Breaking News On - Nnounced that its life science business sector has doubled high potent active pharmaceutical ingredients hpapi production capacity with the expansion of facility in verona - Page 1 : comparemela.com

Merck Opens 59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry's largest manufacturers of these components globally Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTADT, Germany, June 23, 2022 /PRNewswire/ Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new 59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area. "There is an increasing demand for HPAPIs due to their effectiveness against cancer at lower doses and the trend towards more targeted therapeutics. Lower-doses of these therapies reduce the negative side effects for patients who are taking on this critical fight," said Dirk Lange,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.